Evan Lind

5.8k total citations · 2 hit papers
36 papers, 3.2k citations indexed

About

Evan Lind is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Evan Lind has authored 36 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 16 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Evan Lind's work include Immune Cell Function and Interaction (13 papers), CAR-T cell therapy research (11 papers) and Immunotherapy and Immune Responses (10 papers). Evan Lind is often cited by papers focused on Immune Cell Function and Interaction (13 papers), CAR-T cell therapy research (11 papers) and Immunotherapy and Immune Responses (10 papers). Evan Lind collaborates with scholars based in United States, Canada and India. Evan Lind's co-authors include Randolph J. Noelle, Lamis Z. Jarvinen, Sergio A. Quezada, Pamela S. Ohashi, Howard T. Petrie, Susan E. Prockop, Adam J. Lamble, Kathy A. Bennett, Trista E. North and Elaine Dzierzak and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Evan Lind

34 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mast cells are essential intermediaries in regulatory T-cell tolerance

2006 590 citations Li‐Fan Lu, Evan Lind et al. Nature profile →
CD40/CD154 Interactions at the Interface of Tolerance and Immunity

2004 513 citations Evan Lind, Randolph J. Noelle et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evan Lind United States	20	2.0k	970	584	472	388	36	3.2k
Caren Furlonger Canada	21	2.2k 1.1×	1.1k 1.1×	747 1.3×	345 0.7×	343 0.9×	29	3.5k
Idit Shachar Israel	34	2.5k 1.2×	804 0.8×	519 0.9×	200 0.4×	223 0.6×	83	3.6k
Mayumi Naramura United States	29	1.8k 0.9×	1.8k 1.8×	971 1.7×	294 0.6×	294 0.8×	51	3.6k
Satoshi Τακακι Japan	30	1.5k 0.7×	1.2k 1.3×	518 0.9×	267 0.6×	595 1.5×	63	3.4k
Theresa T. Lu United States	29	2.3k 1.2×	1000 1.0×	696 1.2×	175 0.4×	329 0.8×	70	3.7k
Toshihiko Oki Japan	23	956 0.5×	1.2k 1.3×	342 0.6×	230 0.5×	458 1.2×	49	2.5k
Mary J. Janatpour United States	16	1.8k 0.9×	1.1k 1.1×	485 0.8×	150 0.3×	240 0.6×	21	4.0k
Jonathan R. Keller United States	33	1.3k 0.6×	1.7k 1.7×	771 1.3×	218 0.5×	728 1.9×	91	3.4k
Roberta Pelanda United States	35	3.2k 1.6×	1.5k 1.5×	774 1.3×	150 0.3×	266 0.7×	84	4.9k
Marie–Dominique Filippi United States	24	1.2k 0.6×	1.2k 1.3×	281 0.5×	413 0.9×	776 2.0×	55	2.9k

Countries citing papers authored by Evan Lind

Since Specialization

Citations

This map shows the geographic impact of Evan Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Lind more than expected).

Fields of papers citing papers by Evan Lind

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Lind. The network helps show where Evan Lind may publish in the future.

Co-authorship network of co-authors of Evan Lind

This figure shows the co-authorship network connecting the top 25 collaborators of Evan Lind. A scholar is included among the top collaborators of Evan Lind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan Lind. Evan Lind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lind, Evan, et al.. (2024). BCL-2 Inhibitor Venetoclax Shows Synergistic Effects on CD8 T Cell Proliferation and Blast Death in Vitro When Combined with Anti PD-1 Checkpoint Inhibitor. Blood. 144(Supplement 1). 6078–6078. 1 indexed citations

Flynn, Patrick, Mark D. Long, Yoko Kosaka, et al.. (2024). Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency. Frontiers in Immunology. 15. 1297338–1297338. 4 indexed citations

Kosaka, Yoko, et al.. (2023). Using a CRISPR based screen to identify genes dysregulated in AML by T-cells. The Journal of Immunology. 210(Supplement_1). 62.02–62.02.

Romine, Kyle A., Kevin MacPherson‐Hawthorne, Yoko Kosaka, et al.. (2023). BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8+ T cells. Leukemia. 37(3). 580–592. 17 indexed citations

Leonard, Jessica, Yoko Kosaka, Dorian LaTocha, et al.. (2020). Concomitant use of a dual Src/ABL kinase inhibitor eliminates the in vitro efficacy of blinatumomab against Ph+ ALL. Blood. 137(7). 939–944. 17 indexed citations

Liu, Tingting, Adam S. Kittai, Olga V. Danilova, et al.. (2020). Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells. Leukemia. 35(1). 156–168. 31 indexed citations

Wu, Guanming, et al.. (2019). Acute myeloid leukemia–induced T-cell suppression can be reversed by inhibition of the MAPK pathway. Blood Advances. 3(20). 3038–3051. 14 indexed citations

Leonard, Jessica, Yoko Kosaka, Adam J. Lamble, et al.. (2018). Altered T Cell Subsets and Function in Patients with Acute Lymphoblastic Leukemia. Blood. 132(Supplement 1). 1547–1547.

Lamble, Adam J., Yoko Kosaka, Pierrette Lo, et al.. (2015). Defining the Immune Microenvironment in Patients with Acute Myeloid Leukemia. Blood. 126(23). 1374–1374. 1 indexed citations

10.

Chatterjee, Samit, Michael E. Feigin, Don L. Gibbons, et al.. (2012). Dysregulation of Cell Polarity Proteins Synergize with Oncogenes or the Microenvironment to Induce Invasive Behavior in Epithelial Cells. PLoS ONE. 7(4). e34343–e34343. 30 indexed citations

11.

Arpaia, Enrico, Heiko Blaser, Miguel Quintela-Fandiño, et al.. (2011). The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk. Oncogene. 31(7). 884–896. 92 indexed citations

12.

Quintela-Fandiño, Miguel, Enrico Arpaia, Dirk Brenner, et al.. (2010). HUNK suppresses metastasis of basal type breast cancers by disrupting the interaction between PP2A and cofilin-1. Proceedings of the National Academy of Sciences. 107(6). 2622–2627. 37 indexed citations

13.

Lind, Evan, Cory L. Ahonen, Anna Wasiuk, et al.. (2008). Dendritic Cells Require the NF-κB2 Pathway for Cross-Presentation of Soluble Antigens. The Journal of Immunology. 181(1). 354–363. 53 indexed citations

14.

Raman, Vanitha S., Evan Lind, Micah J. Benson, & Randolph J. Noelle. (2007). Strategies for selective priming of memory B cells. Immunology Letters. 109(2). 93–100. 8 indexed citations

15.

Lu, Li‐Fan, Cory L. Ahonen, Evan Lind, et al.. (2007). The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation. Blood. 110(1). 193–200. 21 indexed citations

16.

O’Connor, Brian P., Laura A. Vogel, Weijun Zhang, et al.. (2006). Imprinting the Fate of Antigen-Reactive B Cells through the Affinity of the B Cell Receptor. The Journal of Immunology. 177(11). 7723–7732. 78 indexed citations

17.

Lu, Li‐Fan, Evan Lind, David Gondek, et al.. (2006). Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature. 442(7106). 997–1002. 590 indexed citations breakdown →

18.

North, Trista E., Marella de Bruijn, Terryl Stacy, et al.. (2002). Runx1 Expression Marks Long-Term Repopulating Hematopoietic Stem Cells in the Midgestation Mouse Embryo. Immunity. 16(5). 661–672. 452 indexed citations

19.

Lind, Evan, et al.. (2001). Mapping Precursor Movement through the Postnatal Thymus Reveals Specific Microenvironments Supporting Defined Stages of Early Lymphoid Development. The Journal of Experimental Medicine. 194(2). 127–134. 288 indexed citations

20.

Lind, Evan, et al.. (1999). Bcl-2-Induced Changes in E2F Regulatory Complexes Reveal the Potential for Integrated Cell Cycle and Cell Death Functions. The Journal of Immunology. 162(9). 5374–5379. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact